Estimation of vaccine effectiveness against SARS-CoV-2-associated hospitalization using sentinel surveillance in South Africa

The BNT162b2 vaccine was effective against SARS-CoV-2-associated hospitalization during the Delta period for adults aged ≥18 years, ≥60 years and those HIV-uninfected. VE for Ad26.COV2.S was inconclusive, potentially due to limited sample size or residual confounding. These findings highlight the utility of sentinel surveillance for estimating VE.

Authors

Institutions

Publication Details

Journal
International Journal of Epidemiology
Published
2024-08-14
DOI
https://doi.org/10.1093/ije/dyae116
Citations
3
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
1.17

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Estimation of vaccine effectiveness against SARS-CoV-2-associated hospitalization using sentinel surveillance in South Africa

Aaron M. Samuels, Perrine Marcenac, Mvuyo Makhasi, Halima Dawood et al.
3 citations
International Journal of Epidemiology
SARS-CoV-2 and COVID-19 Research
1.17
article

Estimation of vaccine effectiveness against SARS-CoV-2-associated hospitalization using sentinel surveillance in South Africa

Aaron M. Samuels, Perrine Marcenac, Mvuyo Makhasi, Halima Dawood, Michelle J. Groome, Nicole Wolter, Leora R. Feldstein, Anne von Gottberg, Mignon du Plessis, Jeremy Nel, Kathryn E. Lafond, Sibongile Walaza, Nicola Chiwandire, Ebrahim Variava, Fahima Moosa, Cheryl Cohen
article en
3 citations

Abstract

The BNT162b2 vaccine was effective against SARS-CoV-2-associated hospitalization during the Delta period for adults aged ≥18 years, ≥60 years and those HIV-uninfected. VE for Ad26.COV2.S was inconclusive, potentially due to limited sample size or residual confounding. These findings highlight the utility of sentinel surveillance for estimating VE.

International Journal of EpidemiologyVol. 53(5)
National Health Laboratory Service (ZA), Centers for Disease Control and Prevention (US), National Center for Immunization and Respiratory Diseases (US), University of the Witwatersrand (ZA), Kalafong Hospital (ZA), Grey's Hospital (ZA), National Institute for Communicable Diseases
Wellcome Trust
Good health and well-being
Openalex Percentile: Top 21%
SARS-CoV-2 and COVID-19 Research
1.17
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Estimation of vaccine effectiveness against SARS-CoV-2-associated hospitalization using sentinel surveillance in South Africa — Aaron M. Samuels, Perrine Marcenac, et al. · International Journal of Epidemiology (2024) | TGRS Research Map | TGRS